The sTn antigen is a truncated O-glycan containing a sialic acid α-2,6 linked to GalNAc and is a well-characterised cancer-associated glycan that is upregulated in virtually all epithelial cancers and associated with a poor patient outcomes [40]. The gene discussed is EEF1A2; the disease is cancer.